Feasibility of lung imaging at 0.55T for assessment of interstitial lung disease in patients with pulmonary sarcoidosis - Takeaways - MDSpire

Feasibility of lung imaging at 0.55T for assessment of interstitial lung disease in patients with pulmonary sarcoidosis

  • By

  • Maurice Pradella

  • Hanns-Christian Breit

  • Jens Bremerich

  • Constantinos Anastasopoulos

  • Michael Bach

  • Oliver Bieri

  • Katrin E. Hostettler

  • Grzegorz Bauman

  • June 27, 2026

  • 0 min

Share

  • 1

    The study evaluates 0.55T MRI for assessing interstitial lung disease in pulmonary sarcoidosis patients, addressing limitations of traditional imaging methods.

  • 2

    Fifteen patients with pulmonary sarcoidosis underwent chest CT and 0.55T MRI scans, with a reference cohort of thirty healthy volunteers for normative values.

  • 3

    MRI scans utilized a 0.55-T whole-body scanner and employed advanced bSSFP techniques for high-resolution morphological and functional lung imaging.

  • 4

    Image evaluation involved three radiologists assessing CT and MRI scans for various pulmonary findings, with interrater and inter-modality agreement quantified.

  • 5

    The study aims to establish the feasibility of using low-field MRI in clinical settings for comprehensive lung assessment in sarcoidosis patients.

Original Source(s)

Feasibility of lung imaging at 0.55T for assessment of interstitial lung disease in patients with pulmonary sarcoidosis

  • by Maurice Pradella, Hanns-Christian Breit, Jens Bremerich, Constantinos Anastasopoulos, Michael Bach, Oliver Bieri, Katrin E. Hostettler, Grzegorz Bauman

  • June 27, 2026

Related Content

The invisible “cuneus vein”…does it even exist?

Spectral computed tomography characterization of coronary atherosclerotic plaque: principles, imaging biomarkers, and clinical significance

Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy